Activated natural killer cells accelerate liver damage in patients with chronic hepatitis B virus infection

Clinical and Experimental Immunology

Volumn 180, Issue 3, 2015, Pages 499-508

  Zheng, Q ^a   Zhu, Y Y ^a   Chen, J ^a   Ye, Y B ^b   Li, J Y ^b   Liu, Y R ^a   Hu, M L ^c   Zheng, Y C ^a   Jiang, J J ^a  

^a FUJIAN MEDICAL UNIVERSITY   (China)

^b Fujian Key Laboratory of Translational Cancer Medicine   (China)

^c Jinhua Central Hospital   (China)

Author keywords

Chronic hepatitis B; Cytokine; Innate immunity; Liver injury; Natural killer cells

Indexed keywords

ALANINE AMINOTRANSFERASE; CD69 ANTIGEN; GAMMA INTERFERON; HEPATITIS B(E) ANTIGEN; INTERLEUKIN 12; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE;

ADOLESCENT; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIGEN EXPRESSION; ARTICLE; CD3+ T LYMPHOCYTE; CELL ACTIVATION; CELL SURFACE; CELLULAR DISTRIBUTION; CHRONIC HEPATITIS B; COHORT ANALYSIS; CONTROLLED STUDY; DEGRANULATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOLOGICAL TOLERANCE; INTRACELLULAR SPACE; LIVER BIOPSY; LIVER HISTOLOGY; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER CELL; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; VIRAL CLEARANCE; VIRUS LOAD; VIRUS REPLICATION; BIOPSY; ENZYMOLOGY; HEPATITIS B; HEPATITIS B VIRUS; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; LIVER; LIVER FUNCTION TEST; LYMPHOCYTE ACTIVATION; METABOLISM; MIDDLE AGED; PATHOLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; BIOPSY; CELL DEGRANULATION; CYTOKINES; FEMALE; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; IMMUNOHISTOCHEMISTRY; KILLER CELLS, NATURAL; LIVER; LIVER FUNCTION TESTS; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84929518278     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12597     Document Type: Article

References (29)

1. Wright TL. Introduction to chronic hepatitis B infection. Am J Gastroenterol 2006; 101:S1-6.
2. World Health Organization (WHO). Hepatitis B: Fact Sheet no. 204. Geneva, WHO, 2008. Available at: http://www.who.int/mediacentre/factsheets/fs204/en/ (accessed 22 July 2013).
3. Lok AS. Chronic hepatitis B. N Engl J Med 2002; 346:1682-3.
4. Rehermann B, Nascimbeni M. Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol 2005; 5:215-29.
5. Chang JJ, Lewin SR. Immunopathogenesis of hepatitis B virus infection. Immunol Cell Biol 2007; 85:16-23.
6. Chisari FV, Ferrari C. Hepatitis B virus immunopathogenesis. Annu Rev Immunol 1995; 13:29-60.
7. Maini MK, Boni C, Lee CK et al. The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection. J Exp Med 2000; 191:1269-80.
8. Zhang Z, Zhang S, Zou Z et al. Hypercytolytic activity of hepatic natural killer cells correlates with liver injury in chronic hepatitis B patients. Hepatology 2011; 53:73-85.
9. Zou Y, Chen T, Han M et al. Increased killing of liver NK cells by Fas/Fas ligand and NKG2D/NKG2D ligand contributes to hepatocyte necrosis in virus-induced liver failure. J Immunol 2010; 184:466-75.
10. - primitive progenitors in long-term bone marrow culture. Blood 1992; 80:2182-7.
11. Racanelli V, Rehermann B. The liver as an immunological organ. Heptology 2006; 43:S54-62.
12. Caligiuri MA. Human natural killer cells. Blood 2008; 112:461-9.
13. Notas G, Kisseleva T, Brenner D. NK and NKT cells in liver injury and fibrosis. Clin Immunol 2009; 130:16-26.
14. Andoniou CE, Andrews DM, Degli-Esposti MA. Natural killer cells in viral infection: more than just killers. Immunol Rev 2006; 214:239-50.
15. Oliviero B, Varchetta S, Paudice E et al. Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections. Gastroenterology 2009; 137:1151-60.
16. Ahlenstiel G, Titerence RH, Koh C et al. Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa-dependent manner. Gastroenterology 2010; 138:325-35.
17. Dunn C, Brunetto M, Reynolds G et al. Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage. J Exp Med 2007; 204:667-80.
18. Ganem D, Prince AM. Hepatitis B virus infection - natural history and clinical consequences. N Engl J Med 2004; 350:1118-29.
19. Scheuer PJ. Classification of chronic viral hepatitis: a need for reassessment. J Hepatol 1991; 13:372-74.
20. Mania A, Kaczmarek M, Kemnitz P et al. Alterations in NK cell phenotype in relation to liver steatosis in children with chronic hepatitis C. Inflammation 2013; 36:1004-12.
21. Varchetta S, Oliviero B, Francesca Donato M et al. Prospective study of natural killer cell phenotype in recurrent hepatitis C virus infection following liver transplantation. J Hepatol 2009; 50:314-22.
22. Zhang Z, Chen D, Yao J et al. Increased infiltration of intrahepatic DC subsets closely correlate with viral control and liver injury in immune active pediatric patients with chronic hepatitis B. Clin Immunol 2007; 122:173-180.
23. + NK-cell subset. Blood 2010; 116:3865-74.
24. Rehermann B, Naoumov NV. Immunological techniques in viral hepatitis. J Hepatol 2007; 46:508-20.
25. Chen Y, Sun R, Jiang W, Wei H, Tian Z. Liver-specific HBsAg transgenic mice are oversensitive to Poly(I:C)-induced liver injury in NK cell- and IFN-gamma-dependent manner. J Hepatol 2007; 47:183-90.
26. Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S. Functions of natural killer cells. Nat Immunol 2008; 9:503-10.
27. Shimizu Y. T cell immunopathogenesis and immunotherapeutic strategies for chronic hepatitis B virus infection. World J Gastroenterol 2012; 18:2443-51.
28. Waggoner SN, Cornberg M, Selin LK, Welsh RM. Natural killer cells act as rheostats modulating antiviral T cells. Nature 2011; 481:394-8.
29. Lang PA, Lang KS, Xu HC et al. Natural killer cell activation enhances immune pathology and promotes chronic infection by limiting CD8+ T-cell immunity. Proc Natl Acad Sci USA 2012; 24:1210-5.